SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001204459-10-000254
Filing Date
2010-02-08
Accepted
2010-02-08 09:42:39
Documents
25
Period of Report
2010-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 7390
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 4281
3 slide1.jpg GRAPHIC 33311
4 slide2.jpg GRAPHIC 147710
5 slide3.jpg GRAPHIC 96555
6 slide4.jpg GRAPHIC 81110
7 slide5.jpg GRAPHIC 96001
8 slide6.jpg GRAPHIC 104745
9 slide7.jpg GRAPHIC 59219
10 slide8.jpg GRAPHIC 76181
11 slide9.jpg GRAPHIC 83514
12 slide10.jpg GRAPHIC 50659
13 slide11.jpg GRAPHIC 71051
14 slide12.jpg GRAPHIC 91862
15 slide13.jpg GRAPHIC 81344
16 slide14.jpg GRAPHIC 101780
17 slide15.jpg GRAPHIC 89222
18 slide16.jpg GRAPHIC 48798
19 slide17.jpg GRAPHIC 57616
20 slide18.jpg GRAPHIC 58748
21 slide19.jpg GRAPHIC 82099
22 slide20.jpg GRAPHIC 53219
23 slide21.jpg GRAPHIC 56711
24 slide22.jpg GRAPHIC 96596
25 slide23.jpg GRAPHIC 26035
  Complete submission text file 0001204459-10-000254.txt   2418780
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 10578988
SIC: 2834 Pharmaceutical Preparations